Phase II Study of Erlotinib in Patients With Malignant Pleural Mesothelioma: A Southwest Oncology Group Study
Year: 2007
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Awards: SOUTHWEST ONCOLOGY GROUP, G117886320, G1202672505, G1257575315, G1375689152, G1549000524, G1911575068, G1958973285, G2064543036, G2419449687, G2562936776, G268786457, WESTERN ONCOLOGY RESEARCH CONSORTIUM, Southwest Oncology Group, Ozark Health Ventures, LLC dba Cancer Research for the Ozarks, GRAND RAPIDS CLINICAL ONCOLOGY PROGRAM, G3041257426, SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER, Southeast Cancer Control Consortium, Inc, G3337849518, G3350348941, City of Hope Southwest Oncology Group Clinical Trials, G3710026009, G4094841028, G413878341, Southwest Oncology Group, Dayton Clinical Oncology Program, Southwest Oncology Group, G4292856267, Southwest Oncology Group, G4527800867, G5125348268, G5504618518, SOUTHWEST ONCOLOGY GROUP CA13612, G6109875642, Southwest Oncology Group Treatment Grant, SOUTHWEST ONCOLOGY GROUP, SOUTHWEST ONCOLOGY GROUP, SOUTHWEST ONCOLOGY GROUP STUDIES, University of Colorado Southwest Oncology Group, G712978930, CENTRAL ILLINOIS COMMUNITY CLINICAL ONCOLOGY PROGRAM, SOUTHWEST ONCOLOGY GROUP STUDY, Community Clinical Oncology Program, G763325562, SOUTHWEST ONCOLOGY GROUP (UTAH), SOUTHWEST ONCOLOGY GROUP, Comprehensive Cancer Center Program at Fox Chase, G960417071, Montana Cancer Consortium CCOP, G971274320, Southwest Oncology Group/University of California, Davis
OpenAlex ID: W2152529513